首頁 > 市場調查報告書 > 製藥

基因治療學和RNAi

市場調查報告書

商品編碼

1619223

胞外體市場規模、佔有率、成長分析、按產品、按工作流程、按應用、按最終用途、按地區 - 產業預測，2024-2031 年

Exosomes Market Size, Share, Growth Analysis, By Product (Kits & Reagents, Instruments), By Workflow (Isolation Methods, Downstream Analysis), By Application, By End-Use, By Region - Industry Forecast 2024-2031

出版日期: 2024年12月18日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年胞外體的全球市場規模估值為2.508億美元，從2023年的3.2579億美元成長到2031年的26.4125億美元，在預測期內（2024-2031）預計複合年成長率為29.9%。

細胞外囊泡（EV），通常稱為胞外體，是在各種體液中普遍存在的細胞信使，包括血清、尿液和母乳。它運輸蛋白質和遺傳物質的能力在診斷和治療中發揮重要作用，尤其是在癌症發生率上升的情況下。胞外體市場的主要促進因素包括胞外體分離技術的進步、研究經費的增加以及癌症等疾病發生率的增加，預計到 2023 年癌症將導致近 1000 萬人死亡。此次疫情也是創新的催化劑，以外胞外體為基礎的 COVID-19 疫苗的開發就是例證。這些囊泡有望帶來重要的治療益處，例如藥物傳遞效率和低毒性，從而在未來幾年形成快速成長的疾病檢測和創新治療市場。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東/非洲
- 海灣合作理事會國家
- 南非
- 其他中東/非洲

競爭資訊

前5名企業對比
主要企業市場定位（2023年）
主要市場參與者所採取的策略
近期市場趨勢
公司市場佔有率分析（2023）
主要企業簡介
- 公司簡介
- 產品系列分析
- 按細分市場分類的佔有率分析
- 收益與前一年同期比較（2021-2023）

主要企業簡介

QIAGEN（Germany）
Takara Bio Company（Japan）
Illumina, Inc.（USA）
Thermo Fisher Scientific, Inc.（USA）
Codiak Biosciences（USA）
Exosome Diagnostics（USA）
Evox Therapeutics（UK）
ExCoBio Inc.（South Korea）
Bio-Rad Laboratories Ltd.（USA）
NanoSomix, Inc.（USA）
System Biosciences（SBI）（USA）
Lonza Group（Switzerland）
Miltenyi Biotec（Germany）
Norgen Biotek Corp.（Canada）
AMS Biotechnology（AMSBIO）（UK）
Creative Biolabs（USA）
Capricor Therapeutics（USA）
Aegle Therapeutics（USA）
Anjarium Biosciences（Switzerland）

結論和建議

簡介目錄

Product Code: SQMIG35H2198

Global Exosomes Market size was valued at USD 250.8 million in 2022 and is poised to grow from USD 325.79 million in 2023 to USD 2641.25 million by 2031, growing at a CAGR of 29.9% during the forecast period (2024-2031).

Extracellular vesicles (EVs), commonly known as exosomes, are ubiquitous cell communication agents found across various bodily fluids such as serum, urine, and breast milk. Their ability to transport proteins and genetic material positions them as crucial players in diagnostics and therapeutics, particularly in the face of rising cancer incidents. Key drivers for the EV market include advancements in exosome separation technologies, increased research funding, and the growing incidence of diseases like cancer-projected to account for nearly 10 million deaths in 2023. The pandemic has also catalyzed innovations, exemplified by the development of exosome-based COVID-19 vaccines. These vesicles promise significant therapeutic benefits, including drug delivery efficiency and low toxicity, thereby shaping a burgeoning market for disease detection and innovative treatments in the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Exosomes market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Exosomes Market Segmental Analysis

Global Exosomes Market is segmented by product, workflow, application, end-use and region. Based on product, the market is segmented into kits & reagents, instruments and services. Based on workflow, the market is segmented into isolation methods and downstream analysis. Based on application, the market is segmented into cancer, cardiovascular diseases (CVD), neurodegenerative diseases, infectious diseases and others. Based on end-use, the market is segmented into academic & research institutes, pharmaceutical & biotechnology companies and hospitals & clinical testing laboratories. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Exosomes Market

The growth of the global exosomes market is largely driven by the rising investments in pharmaceutical research and development (R&D) along with life sciences initiatives. Pharmaceutical, biopharmaceutical, and medical device companies allocate substantial resources towards the advancement of innovative drugs and technologies. This investment in R&D is critical for the pharmaceutical industry, which prioritizes the delivery of high-quality, cutting-edge products. Recent trends indicate that major pharmaceutical firms are improving their R&D efficiency through substantial long-term funding and collaborative research ventures, ultimately fueling advancements in exosome technologies and applications across various therapeutic areas.

Restraints in the Global Exosomes Market

The global exosomes market faces significant constraints primarily due to the absence of established standard protocols for exosome development and production. As exosome research remains in its nascent stages, scientists often resort to employing novel techniques and methodologies with little hesitation. This lack of standardization not only presents challenges during the creation of exosomes but also complicates their research, development, and manufacturing processes. While exosomes derived from mesenchymal stem cells (MSCs) are garnering interest for their role as intercellular messengers, there is an urgent need for industry leaders to innovate effective harvesting techniques and develop comprehensive standards for exosome characterization and purification to advance their application in areas like vaccine development, cancer diagnostics, and gene therapy.

Market Trends of the Global Exosomes Market

The Global Exosomes market is experiencing a significant upward trend driven by the increasing recognition of exosomes as a versatile treatment platform for various conditions, notably including COVID-19. Their unique ability to deliver therapeutic cargo while minimizing immune rejection positions exosomes as a promising cell-free therapeutic option for numerous diseases and tissue regeneration applications. The growing interest in exosomal therapy, particularly for respiratory viral infections like SARS-CoV-2, underscores the potential of stem cell-derived exosomes to leverage anti-inflammatory and regenerative properties. This trend indicates a robust future for exosome-based treatments as they gain acceptance in the medical community.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2023
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Case Studies

Global Exosomes Market Size by Product & Service & CAGR (2024-2031)

Market Overview
Kits & Reagents
- Isolation Kits
- Purification Kits
- Detection Kits
Instruments
- Ultracentrifuges
- Flow Cytometers
- Others
Services
- Exosome Isolation Services
- Exosome Characterization Services
- Exosome Profiling Services

Global Exosomes Market Size by Workflow & CAGR (2024-2031)

Market Overview
Isolation Methods
- Ultracentrifugation
- Immunocapture On Beads
- Precipitation
- Filtration
- Others
Downstream Analysis
- Flow Cytometry
- Mass Spectrometry
- Next-Generation Sequencing (NGS)
- Western Blotting
- Others

Global Exosomes Market Size by Application & CAGR (2024-2031)

Market Overview
Cancer
- Lung Cancer
- Breast Cancer
- Prostate Cancer
- Colorectal Cancer
- Others
Cardiovascular Diseases (CVD)
Neurodegenerative Diseases
Infectious Diseases
Others

Global Exosomes Market Size by End-Use & CAGR (2024-2031)

Market Overview
Academic & Research Institutes
Pharmaceutical & Biotechnology Companies
Hospitals & Clinical Testing Laboratories

Global Exosomes Market Size & CAGR (2024-2031)

North America (Product & Service, Workflow, Application, End-Use)
- USA
- Canada
Europe (Product & Service, Workflow, Application, End-Use)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product & Service, Workflow, Application, End-Use)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product & Service, Workflow, Application, End-Use)
- Brazil
- Rest of Latin America
Middle East & Africa (Product & Service, Workflow, Application, End-Use)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2023
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

QIAGEN (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Takara Bio Company (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Illumina, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Codiak Biosciences (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Exosome Diagnostics (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Evox Therapeutics (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ExCoBio Inc. (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories Ltd. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NanoSomix, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
System Biosciences (SBI) (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lonza Group (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Miltenyi Biotec (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Norgen Biotek Corp. (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AMS Biotechnology (AMSBIO) (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Creative Biolabs (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Capricor Therapeutics (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Aegle Therapeutics (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Anjarium Biosciences (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments